Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7569991

Concept 2022-06-01 to
2023-02-28
2021-06-01 to
2022-02-28
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
4,106,000,000 JPY
5,646,000,000 JPY
Non-operating income
Non-operating income
79,000,000 JPY
174,000,000 JPY
Non-operating expenses
Non-operating expenses
107,000,000 JPY
26,000,000 JPY
Ordinary profit (loss)
4,077,000,000 JPY
5,794,000,000 JPY
Extraordinary income
Extraordinary income
JPY
269,000,000 JPY
Extraordinary losses
Extraordinary losses
81,000,000 JPY
155,000,000 JPY
Profit (loss) before income taxes
3,996,000,000 JPY
5,909,000,000 JPY
Profit (loss)
2,619,000,000 JPY
3,948,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.